HelloMask is a new type of mask with the technology that makes it transparent, medically safe and breathable. The transparent surgical face mask will let the wearer’s face and expressions to be visible completely without hampering protection and breathability. Also, it will be easier for healthcare professionals to communicate with those who have hearing impairments as lip reading still be possible.
HelloMask is a 99% biodegradable mask and research is being done to make them completely eco-friendly.
Enables verbal and non-verbal communications (due to mask's transparency) in diverse settings especially for patients with speech and hearing disability.
Anyone can use these masks without any breathability issue as these are made using biomass-based transparent fibres that are placed 100 nanometres apart to form sheets from Empa, a Swiss materials centre.
The material is made using electrospinning, for which electric force is used to produce a mat of polymer fibres, and the researchers have adapted the method slightly for large-scale production.
The material will be generated in spools, from which individual masks can be cut and assembled.
Despite the triple-layered design, the HelloMask is flexible, breathable and biodegradable as well.
The transparent material used for the HelloMask can be made in bulk. Also, it can be formed into mask shapes similar to normal cloth.
Certified in Europe, its unique patented technology combines transparency of material with ease of breath and protection from pathogens.
About the Company
Researchers of the Swiss Federal Laboratories for Materials Science and Technology (Empa) and the Swiss Federal Institute of Technology in Lausanne (EPFL) have jointly developed a fully transparent surgical mask that is intended to replace the three-layer mask normally worn by medical staff.
After completing a CHF 1 million fundraising round, the company is ready to move into the production phase so that it enters the market by early 2021. And, it will partner with Geneva University Hospitals for the clinical testing of its prototypes.